Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling

TGF-β SIGNAL TRANSDUCTION

Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571

A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295

A simplified system for generating recombinant adenoviruses

He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209

Mechanism of activation of the TGF-β receptor

Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,340

Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., & Gauthier, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793

SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7

Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,654

Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors

Goumans, M., Valdimarsdóttir, G., Itoh, S., Rosendahl, A., Sideras, P., & ten Dijke, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,127

TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4

Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C., Miyazono, K., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5353 · Cited by 1,071

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.

Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2021 · Cited by 939

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter

Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 876

Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis

Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 872

Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)

Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755

Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity

Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 737

Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix

ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696

GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex.

Wieser, R., Wrana, J. L., & Massagué, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07214.x · Cited by 689

Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors

Attisano, L. (1993) · Cell · doi:10.1016/0092-8674(93)90488-c · Cited by 639

Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer

Jonk, L. J. C., Itoh, S., Heldin, C., ten Dijke, P., & Kruijer, W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21145 · Cited by 569

Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice

Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563

Characterization of Type I Receptors for Transforming Growth Factor-β and Activin

ten Dijke, P., Yamashita, H., Ichijo, H., Franzèn, P., Laiho, M., Miyazono, K., & Heldin, C. (1994) · Science · doi:10.1126/science.8140412 · Cited by 551

Cloning of a Type I TGF-β Receptor and Its Effect on TGF-β Binding to the Type II Receptor

Ebner, R., Chen, R., Shum, L., et al. (1993) · Science · doi:10.1126/science.8388127 · Cited by 402

Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice

Goumans, M., & Mummery, C. L. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.10853822 · Cited by 376

Type I Receptors Specify Growth-Inhibitory and Transcriptional Responses to Transforming Growth Factor β and Activin

Cárcamo, J. M., Weis‐Garcia, F., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., & Massagué, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3810 · Cited by 373

Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

Yamashita, H., ten Dijke, P., Franzèn, P., Miyazono, K., & Heldin, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32142-7 · Cited by 326

Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads

Candia, A. F., Watabe, T., Hawley, S. H. B., Onichtchouk, D., Zhang, Y. E., Derynck, R., Niehrs, C., & Cho, K. W. Y. (1997) · Development · doi:10.1242/dev.124.22.4467 · Cited by 257

Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors

Chen, Y., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3672 · Cited by 217

Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses

Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin, C., & ten Dijke, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208258200 · Cited by 211

Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling.

Weis‐Garcia, F., & Massagué, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00358.x · Cited by 158

Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1

Lux, A., Attisano, L., & Marchuk, D. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.9984 · Cited by 143

Positive and negative regulation of type II TGF‐β receptor signal transduction by autophosphorylation on multiple serine residues

Luo, K., & Lodish, H. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1970 · Cited by 126

Signaling by chimeric erythropoietin‐TGF‐beta receptors: homodimerization of the cytoplasmic domain of the type I TGF‐beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

Luo, K., & Lodish, H. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00826.x · Cited by 124

Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination.

Hendrix, M. J. C., Seftor, R. E. B., Seftor, E. A., et al. (2002) · PubMed · Cited by 123

TGFβ Signal Transduction

Silvestri, C., Bose, R., Attisano, L., & Wrana, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00070-x · Cited by 64

Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas

Jonson, T., Albrechtsson, E., Axelson, J., et al. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.1.71 · Cited by 63

Localization of Transforming Growth Factor-β Type I and Type II Receptors in Mouse Development

Iseki, S., Osumi, N., Miyazono, K., et al. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1237 · Cited by 61

TGF-alpha, EGF, and their cognate EGF receptor are co-expressed with desmin during embryonic, fetal, and neonatal myogenesis in mouse tongue development

Yamane, A., Mayo, M. L., Bringas, P., Chen, L., Huynh, M., Thai, K., Shum, L., & Slavkin, H. C. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199708)209:4 · Cited by 24

Transforming Growth Factor β (TGFβ) Signaling via Differential Activation of Activin Receptor-like Kinases 2 and 5 during Cardiac Development

Ward, S. M., Desgrosellier, J. S., Zhuang, X., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209668200 · Cited by 16

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985

TGFβ biology in cancer progression and immunotherapy

Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944

Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis

Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933

Signaling Receptors for TGF-β Family Members

Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

Olsen, O. E., Hella, H., Elsaadi, S., Jacobi, C., Martı́nez-Hackert, E., & Holien, T. (2020) · Biomolecules · doi:10.3390/biom10040519 · Cited by 61

Phosphorylation regulation of the interaction between Smad7 and activin type I receptor

Liu, X., Nagarajan, R. P., Vale, W., & Chen, Y. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02718-7 · Cited by 24

Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7

Vestal, K. A., Kattamuri, C., Koyiloth, M., Ongaro, L., Howard, J. A., Deaton, A. M., Ticau, S., Dubey, A., Bernard, D. J., & Thompson, T. B. (2024) · Biochemical Journal · doi:10.1042/bcj20230404 · Cited by 10

Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism

Xu, J., McKeehan, K. A., Matsuzaki, K., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6308 · Cited by 125

Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling

Lebrun, J. J., Takabe, K., Chen, Y., & Vale, W. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0218 · Cited by 103